USPTO serial 99438601
CLARION
Status 602
- Filing date
- Oct 11, 2025
- Status date
- Jun 23, 2026
- Registration date
- —
- Examiner
- SNYDER, NELSON B
Need help with CLARION?
CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Owner
Clarion Therapeutics, Inc
Cambridge, MA, US
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Consulting services in the field of pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development of new products in the field of pharmaceuticals; Research and development services of new pharmaceutical products | ACTIVE | — |
Prosecution history
| Date | Code | Event |
|---|---|---|
| Jun 23, 2026 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Jun 23, 2026 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Mar 9, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Mar 9, 2026 | GNRT | NON-FINAL ACTION E-MAILED |
| Mar 9, 2026 | CNRT | NON-FINAL ACTION WRITTEN |
| Mar 2, 2026 | DOCK | ASSIGNED TO EXAMINER |
| Feb 26, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Oct 11, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED |
| Oct 11, 2025 | NWAP | NEW APPLICATION ENTERED |